Novartis Us Foundation
Novartis US Foundation shows volatile financial performance with no reported officer compensation.
EIN: 136193034 · East Hanover, NJ · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $15.5M |
| Total Expenses | $10.5M |
| Program Spending | 85% |
| Net Assets | $7.7M |
| Transparency Score | 70/100 |
Search Intent Cockpit
Novartis Us Foundation Form 990, Revenue, CEO Pay, and IRS Filing Signals
Novartis Us Foundation is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around Novartis Us Foundation in one place.
Form 990 Filing Summary
10 filing years are available, with latest revenue of $11.1M and expenses of $10.5M.
Revenue and Expenses
Novartis Us Foundation reported $11.1M in revenue and $10.5M in expenses, a surplus of $592K.
Executive Compensation
Officer, director, trustee, and key employee pay is reviewed from IRS 990 compensation disclosures when present.
Charity Score and Red Flags
70/100 mission score, 2 red flags, and 3 strengths are shown from structured and AI review.
Is Novartis Us Foundation Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
IRS 990 Data Cockpit
Where the Money Comes From and Where It Goes
Revenue Source Mix
Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.
Expense Deployment
| Program services | $8.9M (85%) |
Across stored filings, Novartis Us Foundation shows contribution history pending. Next enrichment targets: revenue-source fields, IRS BMF classification.
Decision Cockpit
One-Stop Donor, Research, and Peer Context Hub
| Decision Lens | Signal | What to Inspect Next |
|---|---|---|
| Legitimacy | Some Concerns | Good filing record; 2 red flags identified |
| Mission spend | 85% to programs | Excellent |
| Financial durability | Grade A | 10 stored filing years |
| Peer context | Compare with Dance For The Cure Inc | New Jersey and category context |
Trust Check
Review legitimacy, deductibility, red flags, and filing consistency.
Open charity check →Peer Benchmark
Compare against real state and category peers.
Compare with Dance For The Cure Inc →All New Jersey nonprofits
Local and Sector Spokes
Move into this nonprofit's local market, category, and sector maps.
East Hanover, NJ nonprofitsFollow the Money
Jump into spending, compensation, rankings, and filing-year evidence.
State spending analysisState compensation analysis
Relevant rankings
Donation Decision Flow
From Trust Check to Better Alternatives
Alternative Shopping
Similar Nonprofits Donors Should Compare
Merck Patient Assistance Program Inc
Rahway, NJ · $1.9B revenue · Score 98/100
Compare side-by-sideMedical Dosimetrist Certification Board
Mount Laurel, NJ · $4.3M revenue · Score 92/100
Compare side-by-sideAtlantic Cape Family Support Organization Inc
Northfield, NJ · $1.1M revenue · Score 92/100
Compare side-by-sideJanet H And C Harry Knowles Foundation Inc
Moorestown, NJ · $29.4M revenue · Score 90/100
Compare side-by-sideNext Best Actions
Keep the Investigation Moving
Novartis Us Foundation directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Novartis Us Foundation
Novartis Us Foundation (EIN: 136193034) is a nonprofit organization based in East Hanover, NJ. The organization reported total revenue of $15.5M and total assets of $16.8M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Novartis Us Foundation's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Novartis Us Foundation is a large nonprofit that has been operating for 60 years, with 10 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 18.0%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $11.1M |
| Total Expenses | $10.5M |
| Surplus / Deficit | +$592K |
| Total Assets | $14.9M |
| Total Liabilities | $7.1M |
| Net Assets | $7.7M |
| Operating Margin | 5.3% |
| Debt-to-Asset Ratio | 47.9% |
| Months of Reserves | 17.0 months |
Financial Health Grade: A
In 2023, Novartis Us Foundation reported a surplus of $592K with revenue exceeding expenses, holds 17.0 months of operating reserves (strong position), has a debt-to-asset ratio of 47.9% (moderate leverage).
Financial Trends
Over 10 years of filings (2011–2023), Novartis Us Foundation's revenue has grown at a compound annual growth rate (CAGR) of 18.0%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -5.5% | +54.3% | +9.6% |
| 2022 | +73.3% | -42.9% | +23.0% |
| 2021 | -19.1% | -30.2% | -8.8% |
| 2020 | +200.0% | +453.8% | -28.3% |
| 2019 | +51.1% | +72.4% | +3.0% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1966 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Novartis Us Foundation with a Mission Score of 70 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Novartis Us Foundation allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $592K, with revenue exceeding expenses.
- Debt-to-asset ratio: 47.9%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, suggesting that executive leadership is either uncompensated by the foundation directly, compensated by a parent entity, or operates on a volunteer basis, which is a positive sign for resource allocation.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Novartis Us Foundation's IRS 990 filings:
- Significant revenue and expense volatility, with large deficits in 2020 and 2021.
- High liabilities in certain years, peaking at $8,809,585 in 2021, relative to assets.
Strengths
The following positive indicators were identified for Novartis Us Foundation:
- No reported officer compensation, indicating efficient use of funds at the executive level.
- Maintained a substantial asset base (over $11 million) despite financial fluctuations.
- Positive net income in recent years (2022 and 2023) indicates a return to financial stability.
Frequently Asked Questions about Novartis Us Foundation
Is Novartis Us Foundation a legitimate charity?
Novartis Us Foundation (EIN: 136193034) is a registered tax-exempt nonprofit based in New Jersey. Our AI analysis gives it a Mission Score of 70/100. It has 10 years of IRS 990 filings on record. Total revenue: $15.5M. 2 red flags identified. 3 strengths noted. Financial health grade: A.
How does Novartis Us Foundation spend its money?
Novartis Us Foundation directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Novartis Us Foundation tax-deductible?
Novartis Us Foundation is registered as a tax-exempt nonprofit (EIN: 136193034). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Novartis Us Foundation's spending goes to programs?
Novartis Us Foundation directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
Where is Novartis Us Foundation located?
Novartis Us Foundation is headquartered in East Hanover, New Jersey and files with the IRS under EIN 136193034.
How many years of IRS 990 filings does Novartis Us Foundation have?
Novartis Us Foundation has 10 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $15.5M in total revenue.
What caused the significant expense overruns in 2020 ($17,085,931 expenses vs $8,384,010 revenue) and 2021 ($11,922,830 expenses vs $6,780,440 revenue)?
The provided data does not specify the nature of these large expenditures. Further investigation into the detailed IRS Form 990 filings for those years would be necessary to understand if these were large program grants, capital expenditures, or other operational costs.
How does the Novartis US Foundation fund its operations given the periods of significant deficits?
The foundation likely relies on its substantial asset base, which has consistently been over $11 million, and potentially large, irregular contributions from its parent company, Novartis, to cover expenses that exceed annual revenue.
What is the specific breakdown of program, administrative, and fundraising expenses?
The provided summary data does not offer a detailed breakdown of these expense categories. A full IRS Form 990 would be required to analyze the specific allocation of funds.
What is the relationship between the Novartis US Foundation and Novartis, Inc.?
While not explicitly stated in the financial data, the name suggests a close affiliation with the pharmaceutical company Novartis. This relationship likely influences its funding sources and potentially its program focus.
Filing History
IRS 990 filing history for Novartis Us Foundation showing financial trends over 10 years of public records:
Over 10 years of IRS 990 filings (2011–2023), Novartis Us Foundation's revenue has grown by 626%, moving from $1.5M to $11.1M. Total assets decreased by 7.4% over the same period, from $16.0M to $14.9M. Total functional expenses rose by 486.6%, from $1.8M to $10.5M. In its most recent filing year (2023), Novartis Us Foundation reported a surplus of $592K, with revenue exceeding expenses. The organization holds $7.1M in liabilities against $14.9M in assets (debt-to-asset ratio: 47.9%), resulting in net assets of $7.7M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $11.1M | $10.5M | $14.9M | $7.1M | — | — |
| 2022 | $11.7M | $6.8M | $13.5M | $6.4M | — | View 990 |
| 2021 | $6.8M | $11.9M | $11.0M | $8.8M | — | View 990 |
| 2020 | $8.4M | $17.1M | $12.1M | $4.7M | — | — |
| 2019 | $2.8M | $3.1M | $16.9M | $796K | — | View 990 |
| 2015 | $1.9M | $1.8M | $16.4M | $424K | — | View 990 |
| 2014 | $2.1M | $1.9M | $16.4M | $472K | — | View 990 |
| 2013 | $1.5M | $1.4M | $16.1M | $472K | — | View 990 |
| 2012 | $1.5M | $1.4M | $16.1M | $535K | — | View 990 |
| 2011 | $1.5M | $1.8M | $16.0M | $566K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $11.1M, expenses of $10.5M, and assets of $14.9M (revenue -5.5% year-over-year).
- 2022: Revenue of $11.7M, expenses of $6.8M, and assets of $13.5M (revenue +73.3% year-over-year).
- 2021: Revenue of $6.8M, expenses of $11.9M, and assets of $11.0M (revenue -19.1% year-over-year).
- 2020: Revenue of $8.4M, expenses of $17.1M, and assets of $12.1M (revenue +200.0% year-over-year).
- 2019: Revenue of $2.8M, expenses of $3.1M, and assets of $16.9M (revenue +51.1% year-over-year).
- 2015: Revenue of $1.9M, expenses of $1.8M, and assets of $16.4M (revenue -11.8% year-over-year).
- 2014: Revenue of $2.1M, expenses of $1.9M, and assets of $16.4M (revenue +36.4% year-over-year).
- 2013: Revenue of $1.5M, expenses of $1.4M, and assets of $16.1M (revenue +1.2% year-over-year).
- 2012: Revenue of $1.5M, expenses of $1.4M, and assets of $16.1M (revenue -0.6% year-over-year).
- 2011: Revenue of $1.5M, expenses of $1.8M, and assets of $16.0M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Novartis Us Foundation:
Data Sources and Methodology
This transparency report for Novartis Us Foundation is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.